K Podzimek
Overview
Explore the profile of K Podzimek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
11
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zak P, Chrobak L, Dedic K, Podzimek K
Vnitr Lek
. 2001 May;
46(10):697-703.
PMID: 11344629
Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA) induces in 85% patients complete remission. Complete remission is defined as the condition when signs of activity of the disease are absent,...
2.
Filip S, Vanasek J, Blaha M, Mericka P, Vavrova J, Podzimek K
Neoplasma
. 1999 Dec;
46(3):166-72.
PMID: 10613592
The role of erythropoietin (EPO) plus granulocyte-colony stimulating factor (G-CSF) combination in hemopoietic recovery was studied in patients with high-risk breast carcinoma and compared to a control group of previously...
3.
Zak P, Chrobak L, Podzimek K, Pliskova L, Dedic K
Neoplasma
. 1999 Jan;
45(4):261-5.
PMID: 9890671
Active hairy cell leukemia is associated with an increase of RDW (Red Cell Distribution Width) which normalizes after successful therapy with 2-chlorodeoxyadenosine (2-CdA). To clarify this phenomenon, bone marrow films...
4.
Chrobak L, Zak P, Podzimek K, Stransky P
Acta Medica (Hradec Kralove)
. 1998 May;
41(1):23-6.
PMID: 9588069
Unlabelled: Red cell distribution width (RDW) was examined in 18 patients with hairy cell leukemia (HCL) treated with 2-chlorodeoxyadenosine (2-CdA), in 5 patients treated with Interferon alpha (IFN-alpha) and in...
5.
Zak P, Tauchman M, Maisnar V, Podzimek K, Mirova S, Voglova J, et al.
Vnitr Lek
. 1997 May;
43(5):273-8.
PMID: 9601848
A fully implantable venous port system with a cannula inserted into the central venous system was implanted to 91 patients. The system was used for the administration of different types...
6.
Chrobak L, Zak P, Podzimek K, Pliskova L, Foglova J, Maisnar V, et al.
Acta Medica (Hradec Kralove)
. 1997 Jan;
40(2):41-5.
PMID: 9389210
We treated 19 patients with hairy cell leukemia (HCL) with 2-chlorodeoxyadenosine. 15 patients followed up at least 6 months were evaluated. The follow up period varied between 6 months and...
7.
Zak P, Chrobak L, Podzimek K, Hejcmanova D, Voglova J, Dulicek P, et al.
Vnitr Lek
. 1996 Jul;
42(7):463-6.
PMID: 8928422
The authors describe a female patient suffering from hairy-cell leukaemia. Already at the onset of the disease, apart from marked splenomegaly, sonography revealed marked retroperitoneal lymphadenopathy. During the subsequent course...
8.
Chrobak L, Podzimek K, Pliskova L, Kerekes Z, Zak P, Voglova J, et al.
Neoplasma
. 1996 Jan;
43(5):321-5.
PMID: 8996552
Hairy cell leukemia is a chronic lymphoproliferative disorder of B-cell lineage. Malignant cells express the interleukin-2 receptor (IL-2R) which is released in vitro as well as in vivo. The sera...
9.
Hejcmanova D, Abulgasim H, JEBAVA R, Chrobak L, Podzimek K, Zak P
Cesk Slov Oftalmol
. 1995 Jul;
51(3):152-5.
PMID: 7656350
The authors describe the infiltrations of the cornea in both eyes of a patient (women) who suffered from leukaemia with "long-haired cells". The treatment was successful with 2-chlordeoxyadenosine (Leustatin). Knowledge...
10.
Krejsek J, Kopecky O, Zak P, Podzimek K
Vnitr Lek
. 1995 Jan;
41(1):28-33.
PMID: 7716889
Using immunocytochemical phenotyping, the authors assessed the origin of malignant cells in a patient with malignant centroblastic lymphoma. The lymphoma cells expressed the thymocytic surface molecule CD1, pan T-lymphocytic markers...